Top Markets
Coin of the day
G&E Herbal Biotechnology Co., Ltd. G&E Herbal Biotechnology Co., Ltd.

G&E Herbal Biotechnology Co., Ltd.

4911
Rangering i aksjer #24234
G&E Herbal Biotechnology Co., Ltd. operates as a biopharmaceutical enterprise,... G&E Herbal Biotechnology Co., Ltd. operates as a biopharmaceutical enterprise, concentrating on the innovation and commercialization of advanced botanical extraction technologies and the products derived from them. Its diverse portfolio features a range of botanical anti-aging cosmetic items, including facial foam cleansers, cleansing essences, toners, lightening lotions, essential oils, and moisturizing serums and creams, along with specialized products like the SR-100 botanical essence and bromelain illuminating cleansing mousse. The company also manufactures capsules designed as hepato-protective agents. In the realm of wellness, G&E offers a selection of botanical healthcare products such as ArthrEnergy, Jujubes Polysaccharide, Diabecut, HepatoClean, Astragali Radix, Goji, Prosta, and SR-100 capsules, as well as various products catering to adults. Looking to its future developments, the company is actively pursuing new treatments, including Solarise injection for gynecologic, head, and neck cancers; Apocin capsules intended for non-small cell lung cancer; and SR-T100 Gel, which targets common and genital warts. Beyond its own product lines, G&E Herbal Biotechnology is involved in creating manufacturing technologies for a wide array of dietary supplements and provides expert technical advisory services to other biotechnology organizations. The company was founded in 2002 and is headquartered in Tainan City, Taiwan.
Aksjekurs
$0.91899191
Sist synkronisert: 2026-08-21
Markedsverdi
$63.24M
Endring (1 dag)
0.17%
Endring (1 år)
-39.70%
Land
CN
Handel G&E Herbal Biotechnology Co., Ltd. (4911)

Kategori

Antall utestående aksjer for G&E Herbal Biotechnology Co., Ltd. (4911)
Antall utestående aksjer per August 2026: 0
Ifølge G&E Herbal Biotechnology Co., Ltd. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 0. Ved slutten av August 2026 hadde selskapet 0 utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for G&E Herbal Biotechnology Co., Ltd. (4911) fra 2026 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
Ikke nok data for de angitte datoene.
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
253.90M -
US
62.19M -
NL
396.00M -
US
483.58M -
AU
- -
CH